First human tests begin for new cystic fibrosis treatment
Disease control
Not yet recruiting
This early study aims to check the safety and how the body processes VX-272, a potential new treatment for cystic fibrosis. It will involve 128 healthy volunteers who will receive either the drug or a placebo. Researchers will measure drug levels in the blood and monitor for side…
Phase: PHASE1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC